Sean English, MD
Vascular Surgery · Albertville, ALNPI 1578772513
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.9% of the total across 144 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 19.9% — the pattern of someone who eats at a lot of different presentations.
Across 144 payments — averaging $45.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$1K
- W. L. Gore & Associates, Inc.$1K
- Endologix LLC$939
- Inari Medical, Inc.$785
- Kerecis Limited$429
- Shockwave Medical, Inc$284
- plus $2K from 25 others
What the payments were for
- Food & beverage$6,34496%
- Education$2694%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 26 | $1,313 |
| W. L. Gore & Associates, Inc. | 20 | $1,026 |
| Endologix LLC | 13 | $939 |
| Inari Medical, Inc. | 8 | $785 |
| Kerecis Limited | 7 | $429 |
| Shockwave Medical, Inc | 3 | $284 |
| Smith+Nephew | 5 | $210 |
| Organogenesis Inc. | 9 | $191 |
| Cardiovascular Systems Inc. | 4 | $182 |
| Silk Road Medical, Inc. | 9 | $180 |
| Cook Medical LLC | 5 | $166 |
| Boston Scientific | 1 | $119 |
| Bard Peripheral Vascular, Inc. | 3 | $102 |
| Johnson & Johnson | 5 | $95 |
| AbbVie | 5 | $84 |
| Convatec Inc. | 3 | $70 |
| Lemaitre Vascular, Inc. | 2 | $52 |
| Philips North America LLC | 1 | $43 |
| BD | 1 | $42 |
| Stryker | 1 | $41 |
| Mimedx Group, Inc. | 2 | $36 |
| Teleflex LLC | 1 | $36 |
| Polynovo North America LLC | 2 | $33 |
| KCI USA, Inc. | 1 | $29 |
| Solventum Corporation | 1 | $29 |
| Getinge USA Sales, LLC | 1 | $18 |
| Hartmann USA, Inc. | 1 | $17 |
| Vasorum USA Inc. | 1 | $17 |
| Baxter Healthcare | 1 | $16 |
| Terumo Medical Corporation | 1 | $14 |
| Sanara Medtech Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Kerecis Omega3 SurgiClose$727
- FLOWTRIEVER CATHETER, S$698
- Kerecis Omega3 Marigen$518
- Alto Abdominal Stent Graft System$406
- FlowTriever$348
- ClotTriever$348
- ENDURANT IIS$324
- Kerecis Omega3 GraftGuide$311
- C3 Delivery System$279
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$258
- GORE EXCLUDER Iliac Branch Endoprosthesis$172
- Abre$168
- CareLink$159
- Conformable TAG Thoracic Endoprosthesis$150
- AFX2 Bifurcated Endograft System$150
- Ovation iX Iliac Stent Graft$150
- Endurant$144
- Peripheral Orbital Atherectomy System$138
- Stravix$123
- Grafix$123
How this compares
$6,613 in reported general payments places this provider in the 55th percentile of 61 vascular surgery providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 48 | $36,558 |
| XareltoRivaroxaban | 14 | $13,402 |
| ClopidogrelClopidogrel Bisulfate | 180 | $1,251 |
| Pantoprazole Sodium | 23 | $279 |
| Diazepam | 18 | $17 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $95 | $13,40214 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 61 vascular surgery providers in Alabama.
Other vascular surgery in Albertville
- Albert PacificoBirmingham$5.1M
- Andrew KnottHuntsville$76K
- Brian SellersMontgomery$71K
- Peter PonsFlorence$54K
- Benjamin PearceBirmingham$37K
- William HolmanBirmingham$25K
- Keenan WanamakerMontgomery$23K
- Marco CioppiHuntsville$21K
- Mina JacobMobile$19K
- Stephen HeinzmanBirmingham$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.